Data / Form D filings / EmboMedics, Inc.
EmboMedics, Inc.: Form D filings
EmboMedics, Inc., a biotechnology company in Minneapolis, MN, filed 4 Form D notices with the SEC between 2014 and 2017. The latest, on October 25, 2017, reports $740,775 sold of a $1.3 million offering to 12 investors.
Find out what EmboMedics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 678 Mendelssohn Ave. N., Minneapolis, MN, 55427
- Phone
- (763) 398-5120
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1592901
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 25, 2017 | New notice | $1,300,000 | $740,775 | $559,225 | 12 | Sep 20, 2016 | sec.gov |
| Apr 7, 2016 | Amendment | $4,287,938 | $4,287,938 | $0 | 29 | Jul 1, 2014 | sec.gov |
| Aug 14, 2014 | New notice | $5,000,000 | $846,750 | $4,153,250 | 9 | Jul 1, 2014 | sec.gov |
| Feb 3, 2014 | New notice | $860,000 | $860,000 | $0 | 15 | Jun 18, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jafar Golzarian | Director, Promoter | |
| Robert Cohen | Executive Officer, Director | |
| Robert Halverson | Director | |
| Gerald D. Van Eeckhout | Director | |
| Reza Malek | Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Oct 23, 2017 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what EmboMedics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.